Global Trust Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.92K Sell
40
-40
-50% -$8.62K ﹤0.01% 340
2026
Q1
$16.1K Hold
80
0.01% 338
2025
Q4
$16.5K Hold
80
0.01% 318
2025
Q3
$14.3K Hold
80
0.01% 372
2025
Q2
$12.9K Hold
80
0.01% 366
2025
Q1
$13.6K Hold
80
0.01% 340
2024
Q4
$13.3K Hold
80
0.01% 394
2024
Q3
$13.8K Hold
80
0.01% 368
2024
Q2
$12.3K Hold
80
0.01% 352
2024
Q1
$12.3K Hold
80
0.01% 349
2023
Q4
$12.6K Hold
80
0.01% 327
2023
Q3
$11.7K Hold
80
0.01% 322
2023
Q2
$12.3K Hold
80
0.01% 325
2023
Q1
$12.4K Hold
80
0.01% 307
2022
Q4
$12.3K Hold
80
0.01% 294
2022
Q3
$11K Buy
+80
New +$11.2K 0.01% 310
2020
Q4
Sell
-75
Closed -$12K 405
2020
Q3
$12K Sell
75
-4,175
-98% -$683K 0.01% 257
2020
Q2
$713K Buy
+4,250
New +$667K 0.5% 53
2018
Q4
Sell
-2,100
Closed -$333K 410
2018
Q3
$333K Buy
+2,100
New +$318K 0.23% 106
2018
Q2
Sell
-2,500
Closed -$332K 397
2018
Q1
$332K Buy
+2,500
New +$341K 0.26% 100

Other funds holding FBT

Global Trust Asset Management's FBT Position: Q2 2026 in Review

Global Trust Asset Management reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 50% in Q2 2026, selling an estimated $8.62K and leaving 40 shares worth $9.92K. The position accounts for ﹤0.01% of the portfolio, ranked #340.

Global Trust Asset Management first reported a position in FBT in Q1 2018 and has held it in 20 quarters since. The position peaked at $713K in Q2 2020. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Global Trust Asset Management held 40 shares of First Trust NYSE Arca Biotechnology Index Fund worth $9.92K as of Q2 2026.
  • Global Trust Asset Management sold 40 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $8.62K.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Global Trust Asset Management's portfolio in Q2 2026, its #340 holding.
  • Global Trust Asset Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2018 and has held it in 20 quarters since.
  • Global Trust Asset Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $713K in Q2 2020.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Global Trust Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.